News Releases

Back to News Releases

Pharmaceuticals Analyst Joins SunTrust Robinson Humphrey

Sep 3, 2002

Robert Hazlett, III, has joined SunTrust Robinson Humphrey Capital Markets as a director and senior research analyst covering pharmaceutical and specialty pharmaceutical companies.

He has six years experience covering the sector with UBS Securities, Lehman Brothers, and most recently with Robertson Stephens. Mr. Hazlett's research has been recognized by the annual Institutional Investor and Reuters analyst polls.

With the addition of Mr. Hazlett, SunTrust Robinson Humphrey now has five healthcare analysts covering the full spectrum of biotech, facilities, information technology and diagnostic services, medical technology, and pharmaceuticals sectors. SunTrust Robinson Humphrey's Equity Research Department provides investment analysis on approximately 340 companies and their related industries. Coverage includes leading growth companies in Business Services, Consumer and Retail, Financial Services and Technology, Healthcare, Media and Communications, as well as investment strategy and quantitative analysis.

SunTrust Robinson Humphrey Capital Markets provides equity research, investment banking, institutional sales and trading, and debt capital solutions to growing companies. By combining complementary strengths in products and services with in-depth industry knowledge, SunTrust Robinson Humphrey provides clients with innovative financial strategies and solutions. Based in Atlanta, SunTrust Robinson Humphrey maintains a strategic network of offices in Boston, Miami, Nashville, New York, Orlando, Pittsburgh, Richmond and Tampa. For more information, please visit .


SOURCE: SunTrust Banks, Inc.

CONTACT: Hugh Suhr of SunTrust Robinson Humphrey, +1-404-827-6813